In summary, we successfully confirmed three proteins (Fabp3, NfL, and IL-10) as potentially informative biomarkers to complement established AD biomarkers (Aβ and tau) through a three-centered, North American, non-ADNI study. The gene discussed is NEFL; the disease is Alzheimer disease.